{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:40:47Z","timestamp":1794634847314,"version":"4.9.1"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1038\/s41582-025-01090-x","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T13:02:45Z","timestamp":1747054965000},"page":"394-403","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Dementia with Lewy bodies and Parkinson disease dementia \u2014 the same or different and is it important?"],"prefix":"10.1038","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4539-2039","authenticated-orcid":false,"given":"YuHong","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0422-8398","authenticated-orcid":false,"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"1090_CR1","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41531-019-0106-4","volume":"6","author":"JYY Szeto","year":"2020","unstructured":"Szeto, J. Y. Y. et al. Dementia in long-term Parkinson\u2019s disease patients: a multicentre retrospective study. NPJ Parkinsons Dis. 6, 2 (2020).","journal-title":"NPJ Parkinsons Dis."},{"key":"1090_CR2","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.sleep.2023.12.025","volume":"114","author":"L Liu","year":"2024","unstructured":"Liu, L. et al. Characterization of de novo dementia with Lewy body with different duration of rapid eye movement sleep behavior disorder. Sleep. Med. 114, 101\u2013108 (2024).","journal-title":"Sleep. Med."},{"key":"1090_CR3","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/s41588-021-00785-3","volume":"53","author":"R Chia","year":"2021","unstructured":"Chia, R. et al. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture. Nat. Genet. 53, 294\u2013303 (2021).","journal-title":"Nat. Genet."},{"key":"1090_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","volume":"89","author":"IG McKeith","year":"2017","unstructured":"McKeith, I. G. et al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium. Neurology 89, 88\u2013100 (2017).","journal-title":"Neurology"},{"key":"1090_CR5","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","volume":"7","author":"D Aarsland","year":"2021","unstructured":"Aarsland, D. et al. Parkinson disease-associated cognitive impairment. Nat. Rev. Dis. Prim. 7, 47 (2021).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1090_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","volume":"88","author":"KF Pedersen","year":"2017","unstructured":"Pedersen, K. F., Larsen, J. P., Tysnes, O. B. & Alves, G. Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study. Neurology 88, 767\u2013774 (2017).","journal-title":"Neurology"},{"key":"1090_CR7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1001\/jamaneurol.2022.1133","volume":"79","author":"J Sim","year":"2022","unstructured":"Sim, J., Li, H., Hameed, S. & Ting, S. K. S. Clinical manifestations of early-onset dementia with Lewy bodies compared with late-onset dementia with Lewy bodies and early-onset Alzheimer disease. JAMA Neurol. 79, 702\u2013709 (2022).","journal-title":"JAMA Neurol."},{"key":"1090_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1001\/jamaneurol.2013.3579","volume":"70","author":"R Savica","year":"2013","unstructured":"Savica, R. et al. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol. 70, 1396\u20131402 (2013).","journal-title":"JAMA Neurol."},{"key":"1090_CR9","doi-asserted-by":"publisher","unstructured":"Elder, G. J., Lazar, A. S., Alfonso-Miller, P. & Taylor, J. P. Sleep disturbances in Lewy body dementia: a systematic review. Int. J. Geriatr. Psychiatry https:\/\/doi.org\/10.1002\/gps.5814 (2022).","DOI":"10.1002\/gps.5814"},{"key":"1090_CR10","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/alz.12411","volume":"18","author":"P Choudhury","year":"2022","unstructured":"Choudhury, P. et al. The temporal onset of the core features in dementia with Lewy bodies. Alzheimers Dement. 18, 591\u2013601 (2022).","journal-title":"Alzheimers Dement."},{"key":"1090_CR11","doi-asserted-by":"publisher","first-page":"105285","DOI":"10.1016\/j.parkreldis.2023.105285","volume":"107","author":"SY Chiu","year":"2023","unstructured":"Chiu, S. Y. et al. Sex differences in dementia with Lewy bodies: focused review of available evidence and future directions. Parkinsonism Relat. Disord. 107, 105285 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1090_CR12","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1212\/WNL.0000000000009323","volume":"94","author":"IG McKeith","year":"2020","unstructured":"McKeith, I. G. et al. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology 94, 743\u2013755 (2020).","journal-title":"Neurology"},{"key":"1090_CR13","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3233\/JPD-213007","volume":"12","author":"DS Roos","year":"2022","unstructured":"Roos, D. S., Klein, M., Deeg, D. J. H., Doty, R. L. & Berendse, H. W. Prevalence of prodromal symptoms of Parkinson\u2019s disease in the late middle-aged population. J. Parkinsons Dis. 12, 967\u2013974 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1090_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G., Adena, M. A., Halliday, G. M. & Morris, J. G. The Sydney Multicenter Study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"1090_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.761044","volume":"13","author":"Z Zhou","year":"2021","unstructured":"Zhou, Z. et al. Characteristics of autonomic dysfunction in Parkinson\u2019s disease: a large Chinese multicenter cohort study. Front. Aging Neurosci. 13, 761044 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"1090_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"1090_CR17","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1212\/01.wnl.0000436942.55281.47","volume":"81","author":"TJ Ferman","year":"2013","unstructured":"Ferman, T. J. et al. Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies. Neurology 81, 2032\u20132038 (2013).","journal-title":"Neurology"},{"key":"1090_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1111\/cns.13766","volume":"28","author":"C Pan","year":"2022","unstructured":"Pan, C. et al. Characterizing mild cognitive impairment in prodromal Parkinson\u2019s disease: a community-based study in China. CNS Neurosci. Ther. 28, 259\u2013268 (2022).","journal-title":"CNS Neurosci. Ther."},{"key":"1090_CR19","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/brainsci12020199","volume":"12","author":"DHB Speelberg","year":"2022","unstructured":"Speelberg, D. H. B. et al. Prodromal cognitive deficits and the risk of subsequent Parkinson\u2019s disease. Brain Sci. 12, 199 (2022).","journal-title":"Brain Sci."},{"key":"1090_CR20","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1136\/jnnp-2016-313838","volume":"87","author":"E Kalbe","year":"2016","unstructured":"Kalbe, E. et al. Subtypes of mild cognitive impairment in patients with Parkinson\u2019s disease: evidence from the LANDSCAPE study. J. Neurol. Neurosurg. Psychiatry 87, 1099\u20131105 (2016).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1090_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2022.829098","volume":"14","author":"N Hansen","year":"2022","unstructured":"Hansen, N., Timaus, C., Bouter, C., Lange, C. & Packross, K. Delirium-onset of prodromal dementia with Lewy bodies \u2013 putative brainstem-related pathomechanism and clinical relevance. Front. Aging Neurosci. 14, 829098 (2022).","journal-title":"Front. Aging Neurosci."},{"key":"1090_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1007\/s00415-023-12000-w","volume":"271","author":"CW Gunawardana","year":"2024","unstructured":"Gunawardana, C. W., Matar, E. & Lewis, S. J. G. The clinical phenotype of psychiatric-onset prodromal dementia with Lewy bodies: a scoping review. J. Neurol. 271, 606\u2013617 (2024).","journal-title":"J. Neurol."},{"key":"1090_CR23","doi-asserted-by":"publisher","first-page":"afae046","DOI":"10.1093\/ageing\/afae046","volume":"53","author":"F Gerakios","year":"2024","unstructured":"Gerakios, F. et al. Delirium is more common and associated with worse outcomes in Parkinson\u2019s disease compared to older adult controls: results of two prospective longitudinal cohort studies. Age Ageing 53, afae046 (2024).","journal-title":"Age Ageing"},{"key":"1090_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg, D. et al. Prodromal Parkinson disease subtypes \u2013 key to understanding heterogeneity. Nat. Rev. Neurol. 17, 349\u2013361 (2021).","journal-title":"Nat. Rev. Neurol."},{"key":"1090_CR25","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1111\/bpa.12697","volume":"29","author":"L Patterson","year":"2019","unstructured":"Patterson, L., Rushton, S. P., Attems, J., Thomas, A. J. & Morris, C. M. Degeneration of dopaminergic circuitry influences depressive symptoms in Lewy body disorders. Brain Pathol. 29, 544\u2013557 (2019).","journal-title":"Brain Pathol."},{"key":"1090_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41582-023-00918-8","volume":"20","author":"J Pagonabarraga","year":"2024","unstructured":"Pagonabarraga, J., Bejr-Kasem, H., Martinez-Horta, S. & Kulisevsky, J. Parkinson disease psychosis: from phenomenology to neurobiological mechanisms. Nat. Rev. Neurol. 20, 135\u2013150 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"1090_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.sleep.2023.03.007","volume":"105","author":"L Zhou","year":"2023","unstructured":"Zhou, L. et al. Early- and late-onset of isolated rapid eye movement sleep behavior disorder: a retrospective cohort study. Sleep. Med. 105, 1\u20138 (2023).","journal-title":"Sleep. Med."},{"key":"1090_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13024-019-0306-8","volume":"14","author":"TF Outeiro","year":"2019","unstructured":"Outeiro, T. F. et al. Dementia with Lewy bodies: an update and outlook. Mol. Neurodegener. 14, 5 (2019).","journal-title":"Mol. Neurodegener."},{"key":"1090_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2023.105279","volume":"107","author":"C Mellergaard","year":"2023","unstructured":"Mellergaard, C., Waldemar, G., Vogel, A. & Frederiksen, K. S. Characterising the prodromal phase in dementia with Lewy bodies. Parkinsonism Relat. Disord. 107, 105279 (2023).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1090_CR30","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/mds.27802","volume":"34","author":"S Heinzel","year":"2019","unstructured":"Heinzel, S. et al. Update of the MDS research criteria for prodromal Parkinson\u2019s disease. Mov. Disord. 34, 1464\u20131470 (2019).","journal-title":"Mov. Disord."},{"key":"1090_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.2147\/NSS.S266071","volume":"15","author":"M Figorilli","year":"2023","unstructured":"Figorilli, M. et al. Considering REM sleep behavior disorder in the management of Parkinson\u2019s disease. Nat. Sci. Sleep. 15, 333\u2013352 (2023).","journal-title":"Nat. Sci. Sleep."},{"key":"1090_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49402-x","volume":"15","author":"SE Mastenbroek","year":"2024","unstructured":"Mastenbroek, S. E. et al. Disease progression modelling reveals heterogeneity in trajectories of Lewy-type \u03b1-synuclein pathology. Nat. Commun. 15, 5133 (2024).","journal-title":"Nat. Commun."},{"key":"1090_CR33","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00702-022-02522-4","volume":"129","author":"KA Jellinger","year":"2022","unstructured":"Jellinger, K. A. Morphological basis of Parkinson disease-associated cognitive impairment: an update. J. Neural Transm. 129, 977\u2013999 (2022).","journal-title":"J. Neural Transm."},{"key":"1090_CR34","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3233\/JPD-2011-11046","volume":"1","author":"L Parkkinen","year":"2011","unstructured":"Parkkinen, L. et al. Disentangling the relationship between Lewy bodies and nigral neuronal loss in Parkinson\u2019s disease. J. Parkinsons Dis. 1, 277\u2013286 (2011).","journal-title":"J. Parkinsons Dis."},{"key":"1090_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday, G., Hely, M., Reid, W. & Morris, J. The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathol. 115, 409\u2013415 (2008).","journal-title":"Acta Neuropathol."},{"key":"1090_CR36","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1001\/jamaneurol.2018.4377","volume":"76","author":"E De Pablo-Fernandez","year":"2019","unstructured":"De Pablo-Fernandez, E., Lees, A. J., Holton, J. L. & Warner, T. T. Prognosis and neuropathologic correlation of clinical subtypes of Parkinson disease. JAMA Neurol. 76, 470\u2013479 (2019).","journal-title":"JAMA Neurol."},{"key":"1090_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","volume":"22","author":"A Lenka","year":"2016","unstructured":"Lenka, A., Hegde, S., Jhunjhunwala, K. R. & Pal, P. K. Interactions of visual hallucinations, rapid eye movement sleep behavior disorder and cognitive impairment in Parkinson\u2019s disease: a review. Parkinsonism Relat. Disord. 22, 1\u20138 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"1090_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14698","volume":"150","author":"L Walker","year":"2019","unstructured":"Walker, L., Stefanis, L. & Attems, J. Clinical and neuropathological differences between Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies \u2013 current issues and future directions. J. Neurochem. 150, 467\u2013474 (2019).","journal-title":"J. Neurochem."},{"key":"1090_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding, A. J. & Halliday, G. M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 102, 355\u2013363 (2001).","journal-title":"Acta Neuropathol."},{"key":"1090_CR40","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz, D. H. et al. Hippocampal \u03b1-synuclein in dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J. Neurosci. 37, 1675\u20131684 (2017).","journal-title":"J. Neurosci."},{"key":"1090_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2019.101824","volume":"23","author":"C La","year":"2019","unstructured":"La, C. et al. Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson\u2019s disease. Neuroimage Clin. 23, 101824 (2019).","journal-title":"Neuroimage Clin."},{"key":"1090_CR42","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/brain\/awf033","volume":"125","author":"AJ Harding","year":"2002","unstructured":"Harding, A. J., Broe, G. A. & Halliday, G. M. Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe. Brain 125, 391\u2013403 (2002).","journal-title":"Brain"},{"key":"1090_CR43","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.jns.2006.02.016","volume":"246","author":"R Yamamoto","year":"2006","unstructured":"Yamamoto, R. et al. Investigation of Lewy pathology in the visual pathway of brains of dementia with Lewy bodies. J. Neurol. Sci. 246, 95\u2013101 (2006).","journal-title":"J. Neurol. Sci."},{"key":"1090_CR44","doi-asserted-by":"publisher","unstructured":"Jellinger, K. A. Behavioral disorders in dementia with Lewy bodies: old and new knowledge. J. Neural Transm. https:\/\/doi.org\/10.1007\/s00702-024-02823-w (2024).","DOI":"10.1007\/s00702-024-02823-w"},{"key":"1090_CR45","first-page":"1234","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J. Neurol. Neurosurg. Psychiatry 90, 1234\u20131243 (2019).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1090_CR46","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/bpa.12182","volume":"25","author":"DR Howlett","year":"2015","unstructured":"Howlett, D. R. et al. Regional multiple pathology scores are associated with cognitive decline in Lewy body dementias. Brain Pathol. 25, 401\u2013408 (2015).","journal-title":"Brain Pathol."},{"key":"1090_CR47","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/nan.12648","volume":"47","author":"D Hansen","year":"2021","unstructured":"Hansen, D. et al. Novel clinicopathological characteristics differentiate dementia with Lewy bodies from Parkinson\u2019s disease dementia. Neuropathol. Appl. Neurobiol. 47, 143\u2013156 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1090_CR48","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/alz.12814","volume":"19","author":"JB Toledo","year":"2023","unstructured":"Toledo, J. B. et al. Dementia with Lewy bodies: impact of co-pathologies and implications for clinical trial design. Alzheimers Dement. 19, 318\u2013332 (2023).","journal-title":"Alzheimers Dement."},{"key":"1090_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40478-023-01714-7","volume":"12","author":"L Walker","year":"2024","unstructured":"Walker, L., Simpson, H., Thomas, A. J. & Attems, J. Prevalence, distribution, and severity of cerebral amyloid angiopathy differ between Lewy body diseases and Alzheimer\u2019s disease. Acta Neuropathol. Commun. 12, 28 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"1090_CR50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/NEN.0b013e3181d88e63","volume":"69","author":"E Ghebremedhin","year":"2010","unstructured":"Ghebremedhin, E. et al. Inverse relationship between cerebrovascular lesions and severity of Lewy body pathology in patients with Lewy body diseases. J. Neuropathol. Exp. Neurol. 69, 442\u2013448 (2010).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1090_CR51","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.1111\/ene.16002","volume":"30","author":"J Gan","year":"2023","unstructured":"Gan, J. et al. White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study. Eur. J. Neurol. 30, 3711\u20133721 (2023).","journal-title":"Eur. J. Neurol."},{"key":"1090_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2021.102754","volume":"31","author":"K Kantarci","year":"2021","unstructured":"Kantarci, K. et al. FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. Neuroimage Clin. 31, 102754 (2021).","journal-title":"Neuroimage Clin."},{"key":"1090_CR53","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2023.11.006","volume":"134","author":"KS Chin","year":"2024","unstructured":"Chin, K. S. et al. Prevalence of cerebral microbleeds in Alzheimer\u2019s disease, dementia with Lewy bodies and Parkinson\u2019s disease dementia: a systematic review and meta-analysis. Neurobiol. Aging 134, 74\u201383 (2024).","journal-title":"Neurobiol. Aging"},{"key":"1090_CR54","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1002\/gps.4724","volume":"33","author":"A Nitchingham","year":"2018","unstructured":"Nitchingham, A., Kumar, V., Shenkin, S., Ferguson, K. J. & Caplan, G. A. A systematic review of neuroimaging in delirium: predictors, correlates and consequences. Int. J. Geriatr. Psychiatry 33, 1458\u20131478 (2018).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"1090_CR55","doi-asserted-by":"publisher","first-page":"3146","DOI":"10.1093\/brain\/awr177","volume":"134","author":"JL Cummings","year":"2011","unstructured":"Cummings, J. L. et al. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration. Brain 134, 3146\u20133166 (2011).","journal-title":"Brain"},{"key":"1090_CR56","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/brain\/awad300","volume":"147","author":"P Trujillo","year":"2024","unstructured":"Trujillo, P., Aumann, M. A. & Claassen, D. O. Neuromelanin-sensitive MRI as a promising biomarker of catecholamine function. Brain 147, 337\u2013351 (2024).","journal-title":"Brain"},{"key":"1090_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0309885","volume":"19","author":"Y Inagawa","year":"2024","unstructured":"Inagawa, Y. et al. Utility of neuromelanin-sensitive MRI in the diagnosis of dementia with Lewy bodies. PLoS ONE 19, e0309885 (2024).","journal-title":"PLoS ONE"},{"key":"1090_CR58","doi-asserted-by":"publisher","first-page":"3114","DOI":"10.1093\/brain\/awab191","volume":"144","author":"E Biondetti","year":"2021","unstructured":"Biondetti, E. et al. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson\u2019s disease. Brain 144, 3114\u20133125 (2021).","journal-title":"Brain"},{"key":"1090_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1016-8","volume":"16","author":"KA Jellinger","year":"2018","unstructured":"Jellinger, K. A. & Korczyn, A. D. Are dementia with Lewy bodies and Parkinson\u2019s disease dementia the same disease? BMC Med. 16, 34 (2018).","journal-title":"BMC Med."},{"key":"1090_CR60","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CR Jack Jr.","year":"2024","unstructured":"Jack, C. R. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimers Dement. 20, 5143\u20135169 (2024).","journal-title":"Alzheimers Dement."},{"key":"1090_CR61","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.neuron.2024.05.006","volume":"112","author":"H Endo","year":"2024","unstructured":"Endo, H. et al. Imaging \u03b1-synuclein pathologies in animal models and patients with Parkinson\u2019s and related diseases. Neuron 112, 2540\u20132557.e8 (2024).","journal-title":"Neuron"},{"key":"1090_CR62","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/brain\/awad260","volume":"147","author":"A Chopra","year":"2024","unstructured":"Chopra, A. & Outeiro, T. F. Aggregation and beyond: \u03b1-synuclein-based biomarkers in synucleinopathies. Brain 147, 81\u201390 (2024).","journal-title":"Brain"},{"key":"1090_CR63","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni, T. et al. A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol. 23, 178\u2013190 (2024).","journal-title":"Lancet Neurol."},{"key":"1090_CR64","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf, A. et al. Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative Cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol. 22, 407\u2013417 (2023).","journal-title":"Lancet Neurol."},{"key":"1090_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga, G. M. et al. Performance of a seed amplification assay for misfolded \u03b1-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol. 147, 18 (2024).","journal-title":"Acta Neuropathol."},{"key":"1090_CR66","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts, S. N. et al. Imaging amyloid deposition in Lewy body diseases. Neurology 71, 903\u2013910 (2008).","journal-title":"Neurology"},{"key":"1090_CR67","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.16439","volume":"2","author":"Z Nedelska","year":"2019","unstructured":"Nedelska, Z. et al. Association of longitudinal \u03b2-amyloid accumulation determined by positron emission tomography with clinical and cognitive decline in adults with probable Lewy body dementia. JAMA Netw. Open. 2, e1916439 (2019).","journal-title":"JAMA Netw. Open."},{"key":"1090_CR68","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1002\/mds.26191","volume":"30","author":"M Petrou","year":"2015","unstructured":"Petrou, M. et al. Amyloid deposition in Parkinson\u2019s disease and cognitive impairment: a systematic review. Mov. Disord. 30, 928\u2013935 (2015).","journal-title":"Mov. Disord."},{"key":"1090_CR69","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","volume":"23","author":"P Donaghy","year":"2015","unstructured":"Donaghy, P., Thomas, A. J. & O\u2019Brien, J. T. Amyloid PET imaging in Lewy body disorders. Am. J. Geriatr. Psychiatry 23, 23\u201337 (2015).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"1090_CR70","doi-asserted-by":"publisher","first-page":"e178","DOI":"10.1212\/WNL.0000000000207393","volume":"101","author":"P Diaz-Galvan","year":"2023","unstructured":"Diaz-Galvan, P. et al. \u03b2-Amyloid load on PET along the continuum of dementia with Lewy bodies. Neurology 101, e178\u2013e188 (2023).","journal-title":"Neurology"},{"key":"1090_CR71","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00406-018-0928-9","volume":"270","author":"K Gmitterova","year":"2020","unstructured":"Gmitterova, K. et al. Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson\u2019s disease dementia. Eur. Arch. Psychiatry Clin. Neurosci. 270, 461\u2013470 (2020).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"1090_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134564","volume":"715","author":"T Katayama","year":"2020","unstructured":"Katayama, T. et al. Cerebrospinal fluid levels of \u03b1-synuclein, amyloid \u03b2, tau, phosphorylated tau, and neuron-specific enolase in patients with Parkinson\u2019s disease, dementia with Lewy bodies or other neurological disorders: their relationships with cognition and nuclear medicine imaging findings. Neurosci. Lett. 715, 134564 (2020).","journal-title":"Neurosci. Lett."},{"key":"1090_CR73","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.biopsych.2008.02.016","volume":"64","author":"L Parnetti","year":"2008","unstructured":"Parnetti, L. et al. Cerebrospinal fluid biomarkers in Parkinson\u2019s disease with dementia and dementia with Lewy bodies. Biol. Psychiatry 64, 850\u2013855 (2008).","journal-title":"Biol. Psychiatry"},{"key":"1090_CR74","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00401-022-02453-0","volume":"144","author":"I Martinez-Valbuena","year":"2022","unstructured":"Martinez-Valbuena, I. et al. \u03b1-Synuclein molecular behavior and nigral proteomic profiling distinguish subtypes of Lewy body disorders. Acta Neuropathol. 144, 167\u2013185 (2022).","journal-title":"Acta Neuropathol."},{"key":"1090_CR75","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.3390\/ijms25052676","volume":"25","author":"T Kon","year":"2024","unstructured":"Kon, T. et al. Molecular behavior of \u03b1-synuclein is associated with membrane transport, lipid metabolism, and ubiquitin-proteasome pathways in Lewy body disease. Int. J. Mol. Sci. 25, 2676 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1090_CR76","doi-asserted-by":"publisher","first-page":"3270","DOI":"10.1021\/acschemneuro.4c00185","volume":"15","author":"D Lau","year":"2024","unstructured":"Lau, D. et al. Single-molecule fingerprinting reveals different growth mechanisms in seed amplification assays for different polymorphs of \u03b1-synuclein fibrils. ACS Chem. Neurosci. 15, 3270\u20133285 (2024).","journal-title":"ACS Chem. Neurosci."},{"key":"1090_CR77","doi-asserted-by":"publisher","first-page":"RP93562","DOI":"10.7554\/eLife.93562.4","volume":"12","author":"L Frey","year":"2024","unstructured":"Frey, L. et al. On the pH-dependence of \u03b1-synuclein amyloid polymorphism and the role of secondary nucleation in seed-based amyloid propagation. Elife 12, RP93562 (2024).","journal-title":"Elife"},{"key":"1090_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50692-4","volume":"15","author":"CK Xu","year":"2024","unstructured":"Xu, C. K. et al. \u03b1-Synuclein oligomers form by secondary nucleation. Nat. Commun. 15, 7083 (2024).","journal-title":"Nat. Commun."},{"key":"1090_CR79","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00401-021-02343-x","volume":"142","author":"R Feleke","year":"2021","unstructured":"Feleke, R. et al. Cross-platform transcriptional profiling identifies common and distinct molecular pathologies in Lewy body diseases. Acta Neuropathol. 142, 449\u2013474 (2021).","journal-title":"Acta Neuropathol."},{"key":"1090_CR80","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1186\/s40478-023-01687-7","volume":"11","author":"T Kon","year":"2023","unstructured":"Kon, T. et al. Neuronal SNCA transcription during Lewy body formation. Acta Neuropathol. Commun. 11, 185 (2023).","journal-title":"Acta Neuropathol. Commun."},{"key":"1090_CR81","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/j.cell.2022.05.008","volume":"185","author":"E Hallacli","year":"2022","unstructured":"Hallacli, E. et al. The Parkinson\u2019s disease protein \u03b1-synuclein is a modulator of processing bodies and mRNA stability. Cell 185, 2035\u20132056.e3 (2022).","journal-title":"Cell"},{"key":"1090_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-024-00749-1","volume":"19","author":"A Shantaraman","year":"2024","unstructured":"Shantaraman, A. et al. Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer\u2019s disease. Mol. Neurodegen. 19, 60 (2024).","journal-title":"Mol. Neurodegen."},{"key":"1090_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1029370","volume":"14","author":"J Xu","year":"2023","unstructured":"Xu, J. et al. Identification of key genes and signaling pathways associated with dementia with Lewy bodies and Parkinson\u2019s disease dementia using bioinformatics. Front. Neurol. 14, 1029370 (2023).","journal-title":"Front. Neurol."},{"key":"1090_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-22400-z","volume":"12","author":"M Asghar","year":"2022","unstructured":"Asghar, M. et al. Mitochondrial biogenesis, telomere length and cellular senescence in Parkinson\u2019s disease and Lewy body dementia. Sci. Rep. 12, 17578 (2022).","journal-title":"Sci. Rep."},{"key":"1090_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0202044","volume":"13","author":"V Larsson","year":"2018","unstructured":"Larsson, V., Torisson, G. & Londos, E. Relative survival in patients with dementia with Lewy bodies and Parkinson\u2019s disease dementia. PLoS ONE 13, e0202044 (2018).","journal-title":"PLoS ONE"},{"key":"1090_CR86","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.nbd.2019.04.004","volume":"127","author":"R Guerreiro","year":"2019","unstructured":"Guerreiro, R. et al. Heritability and genetic variance of dementia with Lewy bodies. Neurobiol. Dis. 127, 492\u2013501 (2019).","journal-title":"Neurobiol. Dis."},{"key":"1090_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2020.104782","volume":"137","author":"S Bandres-Ciga","year":"2020","unstructured":"Bandres-Ciga, S., Diez-Fairen, M., Kim, J. J. & Singleton, A. B. Genetics of Parkinson\u2019s disease: an introspection of its journey towards precision medicine. Neurobiol. Dis. 137, 104782 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1090_CR88","doi-asserted-by":"publisher","first-page":"e2076","DOI":"10.1212\/WNL.0000000000009434","volume":"94","author":"DS Smirnov","year":"2020","unstructured":"Smirnov, D. S. et al. Cognitive decline profiles differ in Parkinson disease dementia and dementia with Lewy bodies. Neurology 94, e2076\u2013e2087 (2020).","journal-title":"Neurology"},{"key":"1090_CR89","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1093\/arclin\/acx085","volume":"32","author":"JA Fields","year":"2017","unstructured":"Fields, J. A. Cognitive and neuropsychiatric features in Parkinson\u2019s and Lewy body dementias. Arch. Clin. Neuropsychol. 32, 786\u2013801 (2017).","journal-title":"Arch. Clin. Neuropsychol."},{"key":"1090_CR90","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2024.148881","volume":"1833","author":"C Geng","year":"2024","unstructured":"Geng, C., Tan, L. & Chen, C. Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias. Brain Res. 1833, 148881 (2024).","journal-title":"Brain Res."},{"key":"1090_CR91","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1136\/jnnp.2006.102343","volume":"78","author":"LM Allan","year":"2007","unstructured":"Allan, L. M. et al. Autonomic dysfunction in dementia. J. Neurol. Neurosurg. Psychiatry 78, 671\u2013677 (2007).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"1090_CR92","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1002\/mdc3.14179","volume":"11","author":"YH Hiorth","year":"2024","unstructured":"Hiorth, Y. H., Schulz, J., Pedersen, K. F., Tysnes, O. B. & Alves, G. Orthostatic hypotension and risk of mild cognitive impairment and dementia in Parkinson\u2019s disease. Mov. Disord. Clin. Pract. 11, 1365\u20131372 (2024).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"1090_CR93","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40120-024-00620-x","volume":"13","author":"KA Wyman-Chick","year":"2024","unstructured":"Wyman-Chick, K. A. et al. Differentiating prodromal dementia with Lewy bodies from prodromal Alzheimer\u2019s disease: a pragmatic review for clinicians. Neurol. Ther. 13, 885\u2013906 (2024).","journal-title":"Neurol. Ther."},{"key":"1090_CR94","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1212\/WNL.45.4.669","volume":"45","author":"CG Goetz","year":"1995","unstructured":"Goetz, C. G. & Stebbins, G. T. Mortality and hallucinations in nursing home patients with advanced Parkinson\u2019s disease. Neurology 45, 669\u2013671 (1995).","journal-title":"Neurology"},{"key":"1090_CR95","first-page":"ONNS5189","volume":"19","author":"RS Weil","year":"2020","unstructured":"Weil, R. S. & Reeves, S. Hallucinations in Parkinson\u2019s disease: new insights into mechanisms and treatments. Adv. Clin. Neurosci. Rehabil. 19, ONNS5189 (2020).","journal-title":"Adv. Clin. Neurosci. Rehabil."},{"key":"1090_CR96","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00415-019-09642-0","volume":"268","author":"C Simonet","year":"2021","unstructured":"Simonet, C., Schrag, A., Lees, A. J. & Noyce, A. J. The motor prodromes of Parkinson\u2019s disease: from bedside observation to large-scale application. J. Neurol. 268, 2099\u20132108 (2021).","journal-title":"J. Neurol."},{"key":"1090_CR97","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41531-023-00598-7","volume":"9","author":"A Seger","year":"2023","unstructured":"Seger, A. et al. Clinical subtypes in patients with isolated REM sleep behaviour disorder. NPJ Parkinsons Dis. 9, 155 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1090_CR98","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrneurol.2016.152","volume":"12","author":"RB Postuma","year":"2016","unstructured":"Postuma, R. B. & Berg, D. Advances in markers of prodromal Parkinson disease. Nat. Rev. Neurol. 12, 622\u2013634 (2016).","journal-title":"Nat. Rev. Neurol."},{"key":"1090_CR99","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0891988719845501","volume":"32","author":"E Matar","year":"2019","unstructured":"Matar, E., Phillips, J. R., Martens, K. A. E., Halliday, G. M. & Lewis, S. J. G. Impaired color discrimination \u2013 a specific marker of hallucinations in Lewy body disorders. J. Geriatr. Psychiatry Neurol. 32, 257\u2013264 (2019).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"1090_CR100","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1097\/MS9.0000000000001664","volume":"86","author":"SA Khan","year":"2024","unstructured":"Khan, S. A. et al. Insights into the management of Lewy body dementia: a scoping review. Ann. Med. Surg. 86, 930\u2013942 (2024).","journal-title":"Ann. Med. Surg."},{"key":"1090_CR101","doi-asserted-by":"publisher","first-page":"3334","DOI":"10.1002\/alz.13799","volume":"20","author":"N Samudra","year":"2024","unstructured":"Samudra, N. et al. Clinicopathological correlation of cerebrospinal fluid \u03b1-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement. 20, 3334\u20133341 (2024).","journal-title":"Alzheimers Dement."},{"key":"1090_CR102","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.805135","volume":"12","author":"GD Scott","year":"2021","unstructured":"Scott, G. D. et al. Fluid and tissue biomarkers of Lewy body dementia: report of an LBDA symposium. Front. Neurol. 12, 805135 (2021).","journal-title":"Front. Neurol."},{"key":"1090_CR103","doi-asserted-by":"publisher","first-page":"612","DOI":"10.3390\/medicina58050612","volume":"58","author":"A Foska","year":"2022","unstructured":"Foska, A. et al. Classical cerebrospinal fluid biomarkers in dementia with Lewy bodies. Medicina 58, 612 (2022).","journal-title":"Medicina"},{"key":"1090_CR104","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/s41531-023-00519-8","volume":"9","author":"A Kuzkina","year":"2023","unstructured":"Kuzkina, A. et al. Combining skin and olfactory \u03b1-synuclein seed amplification assays (SAA) \u2013 towards biomarker-driven phenotyping in synucleinopathies. NPJ Parkinsons Dis. 9, 79 (2023).","journal-title":"NPJ Parkinsons Dis."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01090-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01090-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T12:03:00Z","timestamp":1751457780000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-025-01090-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":104,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["1090"],"URL":"https:\/\/doi.org\/10.1038\/s41582-025-01090-x","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"11 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}